Qube Research & Technologies (QRT)’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-106,544	Closed	-$2.46M	–	2631
2020 Q4	$2.46M	Buy	+106,544	New	+$1.35M	0.03%	538

Qube Research & Technologies (QRT)'s PRVL Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 106,544 shares — an estimated $2.46M sold.

Qube Research & Technologies (QRT) first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $2.46M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Qube Research & Technologies (QRT) reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 106,544 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $2.46M.
Qube Research & Technologies (QRT) first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Qube Research & Technologies (QRT)'s Prevail Therapeutics Inc. Common Stock position peaked at $2.46M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.